PT822986E - Antagonistas da interleucina 6 humana totalmente incapazes de se ligarem a gp130 e sua utilizacao para a preparacao de compostos farmaceuticos - Google Patents

Antagonistas da interleucina 6 humana totalmente incapazes de se ligarem a gp130 e sua utilizacao para a preparacao de compostos farmaceuticos

Info

Publication number
PT822986E
PT822986E PT96912205T PT96912205T PT822986E PT 822986 E PT822986 E PT 822986E PT 96912205 T PT96912205 T PT 96912205T PT 96912205 T PT96912205 T PT 96912205T PT 822986 E PT822986 E PT 822986E
Authority
PT
Portugal
Prior art keywords
interleukin
binding
pct
preparation
pharmaceutical compounds
Prior art date
Application number
PT96912205T
Other languages
English (en)
Inventor
Rocco Savino
Gennaro Ciliberto
Giacomo Paonessa
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of PT822986E publication Critical patent/PT822986E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5412—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
PT96912205T 1995-04-28 1996-04-26 Antagonistas da interleucina 6 humana totalmente incapazes de se ligarem a gp130 e sua utilizacao para a preparacao de compostos farmaceuticos PT822986E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT95RM000273A IT1276555B1 (it) 1995-04-28 1995-04-28 Antagonisti di interluchina-6 umana del tutto incapaci di formare un legame con gp 130, e loro uso per la preparazione di composizioni

Publications (1)

Publication Number Publication Date
PT822986E true PT822986E (pt) 2003-07-31

Family

ID=11403338

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96912205T PT822986E (pt) 1995-04-28 1996-04-26 Antagonistas da interleucina 6 humana totalmente incapazes de se ligarem a gp130 e sua utilizacao para a preparacao de compostos farmaceuticos

Country Status (11)

Country Link
US (1) US5972902A (pt)
EP (1) EP0822986B1 (pt)
JP (2) JP3373856B2 (pt)
AT (1) ATE233320T1 (pt)
CA (1) CA2218372C (pt)
DE (1) DE69626387T2 (pt)
DK (1) DK0822986T3 (pt)
ES (1) ES2191096T3 (pt)
IT (1) IT1276555B1 (pt)
PT (1) PT822986E (pt)
WO (1) WO1996034104A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3824173B2 (ja) * 1995-11-07 2006-09-20 株式会社カネカ 自己抗原
WO1997029201A2 (de) * 1996-02-07 1997-08-14 Max-Delbrück-Centrum für Molekulare Medizin Retroviraler vektor für den gentransfer eines il6-antagonisten in humane hämatopoetische stammzellen
ATE547119T1 (de) 1997-03-21 2012-03-15 Chugai Pharmaceutical Co Ltd Präventives oder therapeutisches mittel mit einem il-6-antagonisten als wirkstoff für durch sensibilisierte t-zellen vermittelte erkrankungen
IT1291932B1 (it) * 1997-06-20 1999-01-21 Angeletti P Ist Richerche Bio Composizioni farmaceutiche antitumorali capaci anche di ridurre la farmacoresistenza in cellule tumorali, in particolare di carcinoma
KR100694005B1 (ko) 2000-03-06 2007-03-12 시그마타우 인두스트리에 파르마슈티케 리우니테 에스.피.에이. 높은 아로마타제 수준을 특징으로 하는 질병의 치료를위한 인터류킨-6 길항물질의 용도
KR20100120246A (ko) * 2001-11-14 2010-11-12 센토코 오르토 바이오테크 인코포레이티드 항 ｉｌ-6 항체, 조성물, 방법 및 용도
US20050100550A1 (en) * 2003-11-10 2005-05-12 Mohit Trikha Anti-angiogenic uses of IL-6 antagonists
ITRM20050103A1 (it) * 2005-03-10 2006-09-11 Rocco Savino Associazione di antagonisti della interleuchina 6 e farmaci antiproliferativi.
PE20061324A1 (es) 2005-04-29 2007-01-15 Centocor Inc Anticuerpos anti-il-6, composiciones, metodos y usos
US8188235B2 (en) 2008-06-18 2012-05-29 Pfizer Inc. Antibodies to IL-6 and their uses

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994009138A1 (en) * 1992-10-20 1994-04-28 Cetus Oncology Corporation Interleukin-6 receptor antagonists
IT1261787B (it) * 1993-06-23 1996-06-03 Angeletti P Ist Richerche Bio Metodologia per la selezione di superagonisti, antagonisti e super- antagonisti di ormoni del cui complesso recettoriale fa parte gp 130.

Also Published As

Publication number Publication date
ATE233320T1 (de) 2003-03-15
DK0822986T3 (da) 2003-04-28
ITRM950273A1 (it) 1996-10-28
WO1996034104A1 (en) 1996-10-31
ITRM950273A0 (it) 1995-04-28
JPH10506538A (ja) 1998-06-30
DE69626387D1 (de) 2003-04-03
CA2218372A1 (en) 1996-10-31
IT1276555B1 (it) 1997-11-03
DE69626387T2 (de) 2003-12-11
JP2003153691A (ja) 2003-05-27
JP3373856B2 (ja) 2003-02-04
EP0822986B1 (en) 2003-02-26
EP0822986A1 (en) 1998-02-11
ES2191096T3 (es) 2003-09-01
US5972902A (en) 1999-10-26
CA2218372C (en) 2001-07-31

Similar Documents

Publication Publication Date Title
FI963101A (fi) Anti-TNF-vasta-aineiden käyttö lääkkeenä sellaisten sairauksien hoitoon, joissa seerumin interleukiini-6-taso on kohonnut
BRPI0410746A (pt) compostos e composições imunossupressoras
TR199900318T2 (xx) IL-8 resept�r antagonistleri.
BG109311A (en) PHARMACEUTICAL COMPOSITION, INCLUDING HUMAN ANTIBODIES CONNECTING HUMAN TNFAL, AND HIS APPLICATION
PT822986E (pt) Antagonistas da interleucina 6 humana totalmente incapazes de se ligarem a gp130 e sua utilizacao para a preparacao de compostos farmaceuticos
DK0800519T3 (da) Steroidreceptormodulatorforbindelser og fremgangsmåder
HUP0303952A2 (hu) Terápiás ágens gyermekkori krónikus artrítiszhez hasonló betegségekre
BRPI0409910A (pt) métodos para o tratamento de doenças relacionadas com interleucina-6
ES2144386T1 (es) Ligando para el activador receptor de nf-kappa b, cuyo ligando es miembro de la superfamilia tnf.
ATE450508T1 (de) Substituierte piperidinen mit selektiver bindungsfähigkeit zu histamin h3-rezeptoren
ATE360032T1 (de) Cystein-reiche rezeptoren-train
BR0114410A (pt) Associação de um antagonista de receptor cb1 e de sibutramina, as composições farmacêuticas que os contêm e a respectiva utilização para o tratamento da obesidade
DK1141286T3 (da) Kæde af cytokinreceptorer
NO307784B1 (no) Polysubstituerte 3-acylamino-5-fenyl-1,4-benzodiazepin-2-on- derivater, farmasøytiske blandinger inneholdende dem og mellomprodukter for fremstilling derav
DK0613499T3 (da) Humame IT-4-mutantproteiner
IL129527A0 (en) A pharmaceutical composition containing soluble lymphotoxin-beta receptors
WO2000002582A3 (en) Treatment of celiac disease with interleukin-15 antagonists
EP0816496A3 (de) Nierenkarzinom-spezifische-T-Zellen
BR9812773A (pt) "alfa-amino-epsilon-caprolactamas policìclicas e compostos relacionados"
DE69819012D1 (de) Pharmazeutische zusammensetzung zur reduzierung der mcp-1 proteinsynthese
IT8819835A0 (it) Composizione dietetica eprocedimento per la sua preparazione.
HUP9903619A2 (hu) 5HT2c Antagonistát és D2 antagonistát tartalmazó gyógyszerkészítmény
BR9812368A (pt) 2-aminotetralinas, processo para sua preparação, e composições farmacêuticas, para a prevenção e tratamento terapêutico de patologias inflamatórias e/ou autoimunes
DK0983361T3 (da) Bakterielle pheromoner og anvendelser deraf
MX9803791A (es) Intermediarios novedosos y su uso para preparar bisindolilmaleimidas n,n'-puenteadas.